Wedbush Securities Inc Cidara Therapeutics, Inc. Transaction History

Wedbush Securities Inc

  • $2.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 01, 2019
SELL
$1.49 - $2.94 $23,914 - $47,187
-16,050 Closed
0 $0
Q1 2019

Apr 17, 2019
SELL
$2.35 - $3.27 $4,700 - $6,540
-2,000 Reduced 11.08%
16,050 $43,000
Q2 2018

Aug 03, 2018
SELL
$3.75 - $6.05 $13,875 - $22,385
-3,700 Reduced 17.01%
18,050 $94,000
Q1 2018

May 01, 2018
BUY
$4.0 - $8.15 $87,000 - $177,262
21,750 New
21,750 $87,000

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.43B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email